The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConygar Inv Regulatory News (CIC)

Share Price Information for Conygar Inv (CIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.50
Bid: 75.00
Ask: 80.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.667%)
Open: 77.50
High: 77.50
Low: 77.50
Prev. Close: 77.50
CIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Debt Facility

28 Apr 2016 13:37

RNS Number : 6967W
Conygar Investment Company PLC(The)
28 April 2016
 

 

For immediate release

 

28 April 2016

 

THE CONYGAR INVESTMENT COMPANY PLC

NEW DEBT FACILITY

The Conygar Investment Company PLC ("Conygar" or the "Company"), the property investment and development group, announces that it has completed a new five year £48.1 million loan with Lloyds Bank PLC, Jersey Branch ("Lloyds"), secured on twenty-five group properties. The loan has an interest cost of 1.9% margin plus Bank of England Base Rate, so currently a total cost of 2.4% per annum.

 

The loan replaces our two previous facilities with The Royal Bank of Scotland PLC ("RBS"), which were secured upon this portfolio of assets. One facility, which had an interest rate of 3 month LIBOR plus 3.5% margin and an outstanding balance of £6.9 million, expired this month. The second loan was due to expire in February 2018 and had an interest cost of 3 month LIBOR plus a margin of 3% and a balance of £19 million. Both loans have been repaid and there were no early repayment charges.

 

£26.1 million of the new £48.1 million loan has been used to redeem the RBS loans referred to above and the remaining funds, totalling more than £21 million after transaction costs, are released to enable the Company to pursue other investment and development opportunities.

 

Robert Ware, Chief Executive of Conygar commented:

 

"We are pleased to secure the refinancing of this portfolio for the medium term. We believe that this financing deal is a very competitive one and we look forward to working with Lloyds in the coming years."

 

Stephen Ogborn, Head of Commercial Banking, Lloyds Jersey added:

 

"We are delighted to have completed this transaction and to be starting a new relationship with this strong management team. We look forward to supporting Conygar in the coming years."

 

Enquiries:

The Conygar Investment Company PLC

Robert Ware/Ross McCaskill: 020 7258 8670

 

Liberum Capital Limited (Nominated Adviser and Broker)

Richard Bootle: 020 3100 2222

 

Temple Bar Advisory (Public Relations)

Alex Child-Villiers: 07795 425580

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGZDZRVGVZM
Date   Source Headline
16th Feb 20247:00 amRNSSubmission of Planning Application
29th Jan 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20249:11 amRNSDirector/PDMR Shareholding
22nd Jan 20247:00 amRNSRelated Party Transactions
16th Jan 20247:00 amRNSDirector/PDMR Shareholding
19th Dec 202312:00 pmRNSResults of Annual General Meeting
19th Dec 20237:00 amRNSRelated Party Transactions
14th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSPRELIMINARY RESULTS
16th Nov 20237:00 amRNSNew Debt Facility
9th Nov 20237:00 amRNSNotification of Major Holdings
9th Nov 20237:00 amRNSNotification of Major Holdings
3rd Oct 20234:16 pmRNSPublication of ZDP Listing Document
2nd Oct 20238:00 amRNSResult of ZDP Issue
28th Sep 20237:00 amRNSLaunch of ZDP Issue
22nd Sep 20234:21 pmRNSHolding(s) in Company
31st May 20237:00 amRNSInterim Results
22nd May 20237:00 amRNSUpdate regarding ZDP Issue
18th May 20237:00 amRNSPlanning approved for bioscience development
5th May 20234:38 pmRNSExtension of ZDP Timetable
6th Apr 20231:48 pmRNSPotential Acquisition of Bristol Site
31st Mar 202312:30 pmRNSPublication of ZDP Prospectus
24th Mar 20234:07 pmRNSHaverfordwest – Completion of Sale
24th Mar 20237:00 amRNSFreeport status for Anglesey
20th Mar 20237:00 amRNSSale of Haverfordwest
28th Dec 20227:00 amRNSNEW DEBT FACILITIES AND PROPOSED ZDP ISSUE
19th Dec 202211:35 amRNSConygar - Results of AGM
2nd Dec 20227:00 amRNSPlanning Application for the Island Quarter
22nd Nov 20227:00 amRNSPreliminary Results
29th Jul 202210:23 amRNSDirector/PDMR Shareholding
5th Jul 20229:23 amRNSDirector/PDMR Shareholding
16th Jun 20222:49 pmRNSInvestigation of Debt Capital Options
25th May 202211:19 amRNSExclusivity extended at Bristol site
24th May 20227:00 amRNSResolution to grant planning
10th May 20227:00 amRNSInterim Results
28th Mar 202211:30 amRNSResult of General Meeting
3rd Mar 20225:22 pmRNSPosting of Circular and Notice of GM
10th Feb 20227:00 amRNSSale of Cross Hands Retail Park
4th Jan 202210:53 amRNSTotal Voting Rights
23rd Dec 20212:23 pmRNSTR-1: Notification of major holdings
22nd Dec 20213:21 pmRNSSale of Selly Oak Property
22nd Dec 202110:43 amRNSDirector/PDMR Shareholding
20th Dec 20215:04 pmRNSResult of AGM and Equity Raise update
17th Dec 20214:15 pmRNSResult of Placing
17th Dec 20217:00 amRNSProposed Placing
9th Dec 20217:00 amRNSPotential Development Acquisition in Bristol
29th Nov 20218:34 amRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSPreliminary Results
22nd Oct 20217:00 amRNSFurther planning application Holyhead Waterfront
1st Oct 20217:00 amRNSShare Buyback Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.